Open access · CC-BY
via OpenAlex
Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function
Yu Ding, Yongwen Zhou, Ping Ling, Xiaojun Feng, Sihui Luo, Xueying Zheng, Peter J. Little, Suowen Xu, Jianping Weng
Theranostics · 2021 · ▲ 123 citations
Abstract
As a first-line treatment for diabetes, the insulin-sensitizing biguanide, metformin, regulates glucose levels and positively affects cardiovascular function in patients with diabetes and cardiovascular complications. Endothelial dysfunction (ED) represents the primary pathological change of multiple vascular diseases, because it causes decreased arterial plasticity, increased vascular resistance, reduced tissue perfusion and atherosclerosis. Caused by "biochemical injury", ED is also an independent predictor of cardiovascular events. Accumulating evidence shows that metformin improves ED through liver kinase B1 (LKB1)/5'-adenosine monophosphat-activated protein kinase (AMPK) and AMPK-independent targets, including nuclear factor-kappa B (NF-κB), phosphatidylinositol 3 kinase-protein kinase B (PI3K-Akt), endothelial nitric oxide synthase (eNOS), sirtuin 1 (SIRT1), forkhead box O1 (FOXO1), krüppel-like factor 4 (KLF4) and krüppel-like factor 2 (KLF2). Evaluating the effects of metformin on endothelial cell functions would facilitate our understanding of the therapeutic potential of metformin in cardiovascular diabetology (including diabetes and its cardiovascular complications). This article reviews the physiological and pathological functions of endothelial cells and the intact endothelium, reviews the latest research of metformin in the treatment of diabetes and related cardiovascular complications, and focuses on the mechanism of action of metformin in regulating endothelial cell functions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.7150/thno.64706
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Ding, Y., Zhou, Y., Ling, P., Feng, X., Luo, S., Zheng, X., Little, P.J., Xu, S., & Weng, J. (2021). Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. <em>Theranostics</em>. https://doi.org/10.7150/thno.64706
Vancouver
Ding Y, Zhou Y, Ling P, Feng X, Luo S, Zheng X, et al. Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. Theranostics. 2021. doi:10.7150/thno.64706.
BibTeX
@article{yu2021Metfor,
title = {Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function},
author = {Yu Ding and Yongwen Zhou and Ping Ling and Xiaojun Feng and Sihui Luo and Xueying Zheng and Peter J. Little and Suowen Xu and Jianping Weng},
journal = {Theranostics},
year = {2021},
doi = {10.7150/thno.64706},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Cardiovascular Pharmacology 2015
Citation only
SIRT1 in Endothelial Cells as a Novel Target for the Prevention of Early Vascular Aging
Journal of Cardiovascular Development and Disease 2024
Open access · CC-BY
Endothelial Dysfunction and Cardiovascular Disease: Hyperbaric Oxygen Therapy as an Emerging Therapeutic Modality?
Journal of cardiovascular development and disease 2024
Open access · OA
Endothelial Dysfunction and Cardiovascular Disease: Hyperbaric Oxygen Therapy as an Emerging Therapeutic Modality?
Food & Function 2021
Open access · CC-BY
Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes
Molecular Medicine Reports 2022
Open access · CC-BY
Taurine attenuates ER stress‑associated apoptosis and catabolism in nucleus pulposus cells
International Journal of Molecular Sciences 2019
Open access · CC-BY